NEW YORK (GenomeWeb) – Qiagen reported after the close of the market Tuesday that its first quarter sales increased 4 percent year over year with growth across all regions and customer classes.

The firm reported total sales of $317.1 million for the three months ended March 31, up from $303.6 million. On an adjusted basis, its sales for the quarter were up 5 percent to $317.4 million at constant exchange rates. It beat the consensus Wall Street estimate of $316.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.